Tag: nasal steroids

NEW GUIDELINES FOR ALLERGIC RHINITIS CHANGE TREATMENT

FCAAIA Notes: Allergies rhinitis (nasal allergies) affect 15-20% of the population.  Although many people “just live with it”, many also do not recognize the impact allergies have on their quality of life.  Nasal congestion is the symptom by  which people are most bothered, but fatigue, lack of concentration, and poor school or work performance are all major effects of poorly controlled allergies.

Allergies are a chronic, not an episodic disease.  However, allergies are still often treated only episodically.  These updated guidelines confirm what we already knew. Intranasal steroid sprays are the best choice for prevention of allergy symptoms. Several are available over the counter and are designed to be used every day. They are incredibly safe, Continue reading “NEW GUIDELINES FOR ALLERGIC RHINITIS CHANGE TREATMENT”

UPDATES IN THE MANAGEMENT OF SEASONAL ALLERGIC RHINITIS

FCAAIA Notes: This article is a concise review of medication options for treating nasal allergies. It does not go in to the specifics of one medication as compared to another.  The one glaring omission is that there is no discussion of immunotherapy, a potential cure for allergies. Continue reading “UPDATES IN THE MANAGEMENT OF SEASONAL ALLERGIC RHINITIS”

UPDATES IN THE MANAGEMENT OF SEASONAL ALLERGIC RHINITIS

FCAAIA Notes: Everyone with allergies should make an attempt to decrease exposure to his or her triggers.  Everyone should try to find an effective symptom reliever to use as needed.  Everyone with moderate symptoms should use daily controller mediations. And, in accordance with current guidelines and practice parameters, everyone with moderate allergic rhinitis is a potential candidate for allergen immunotherapy (allergy shots).

BUT WAIT!  This review doesn’t even mention immunotherapy as an option and I don’t know why.  Immunotherapy has the potential to cure, not just control one’s disease Continue reading “UPDATES IN THE MANAGEMENT OF SEASONAL ALLERGIC RHINITIS”

Skip to content